MedPeer,Inc. (MDPEF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MedPeer,Inc. (MDPEF) trades at $1.96 with AI Score 49/100 (Grade C). MedPeer,Inc. operates a comprehensive web platform providing various digital services for doctors and medical students across Japan. Market cap: $42.59M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for MDPEF: MDPEF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDPEF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MDPEF: the 1 perspectives are evenly split.
How is this calculated? →MedPeer,Inc. (MDPEF) Healthcare & Pipeline Overview
MedPeer,Inc. is a Tokyo-based healthcare information services provider, operating a comprehensive web platform for doctors and medical students in Japan. The company offers online case consultations, clinical knowledge content, drug evaluation forums, and specialized recruitment services, positioning itself as a key digital resource for medical professionals in the Japanese market.
What Is the Investment Thesis for MDPEF?
MedPeer,Inc. presents an investment thesis centered on its established position within Japan's digital healthcare information services market, serving a critical professional demographic of doctors and medical students. The company's comprehensive platform, encompassing services from online consultations and clinical education to recruitment and clinic support, creates a strong network effect among its user base. Key financial metrics include a P/E ratio of 34.7 and a gross margin of 44.7%, indicating profitability and efficient operations relative to its revenue. A profit margin of 4.8% suggests a focused approach to cost management. The company's beta of 2.00 indicates higher volatility compared to the broader market, which could appeal to investors seeking higher risk-reward profiles. Growth catalysts are anticipated through continued expansion of its user base within Japan, diversification of service offerings to address evolving medical professional needs, and potential for increased monetization of its specialized recruitment and clinic support platforms. The company's dividend yield of 0.65% also offers a modest return component. Risks include intense competition in the digital healthcare space, regulatory changes in Japan's healthcare sector, and the inherent challenges of operating as an OTC-traded entity with potentially lower liquidity and disclosure levels.
Based on FMP financials and quantitative analysis
MDPEF Key Highlights
- Market capitalization of $42.59M reflects its current valuation as a specialized player in the Japanese healthcare information services market.
- A P/E ratio of 34.7 indicates investor expectations for future earnings growth relative to its current profitability.
- Gross margin of 44.7% demonstrates strong operational efficiency in delivering its digital services to medical professionals.
- A profit margin of 4.8% highlights the company's ability to convert revenue into net income, supporting its ongoing operations and potential for reinvestment.
- Beta of 2.00 suggests that the stock's price movements are twice as volatile as the overall market, indicating higher risk and potential for greater price swings.
Who Are MDPEF's Competitors?
MDPEF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.72 | +3.54% | $8.46M | 54 |
| CERN Cerner Corporation | $94.92 | +0.00% | 54 | |
| CRVW CareView Communications, Inc. | $0.05 | -8.31% | $30.65M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDPEF's Key Strengths?
- Established and comprehensive digital platform for Japanese medical professionals.
- Diverse service offerings including education, consultation, recruitment, and clinic support.
- Strong network effect among doctors and medical students in Japan.
- Solid gross margin of 44.7% indicating efficient service delivery.
What Are MDPEF's Weaknesses?
- Relatively small market capitalization of $42.59M, potentially limiting access to capital.
- Profit margin of 4.8% suggests room for improvement in overall profitability.
- High Beta of 2.00 indicates significant stock price volatility.
- Disclosure status on the OTC market is 'Unknown', which can deter institutional investors.
What Could Drive MDPEF Stock Higher?
- Expansion of the MedPeer platform's user base through targeted marketing campaigns and enhanced feature sets within Japan, potentially increasing subscription and advertising revenues.
- Introduction of new specialized services or content modules on the MedPeer platform, which could attract new users and deepen engagement among existing medical professionals.
- Strategic partnerships with pharmaceutical companies or healthcare institutions in Japan, leading to increased advertising revenue or new service development opportunities.
- Growth in the MedPeer CAREER segment, driven by increased demand for doctor recruitment services and successful placement rates, contributing to higher service fees.
- Development and launch of advanced features for MedPeer CLINIC SUPPORT, offering more comprehensive solutions for clinic establishment and management, thereby expanding its revenue streams.
What Are the Key Risks for MDPEF?
- Rich valuation — a P/E of 34.7 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Intense competition within the Japanese digital healthcare information services market could limit MedPeer,Inc.'s market share and pricing power.
- Regulatory changes in Japan's healthcare sector or data privacy laws could necessitate costly platform adjustments or impact service delivery.
- The inherent risks associated with trading on the OTC Other market, including lower liquidity, limited disclosure, and potential for price volatility, could deter institutional investors.
- Dependence on the Japanese medical community for its user base and revenue, making the company susceptible to local economic downturns or shifts in healthcare policy.
- Failure to continuously innovate and adapt its platform to evolving technological trends and medical professional needs could lead to user attrition.
What Are the Growth Opportunities for MDPEF?
- **Deepening Penetration within the Japanese Medical Community:** MedPeer,Inc. has a significant opportunity to expand its user base and engagement among the existing population of doctors and medical students in Japan. By enhancing platform features, offering more personalized content, and improving user experience, the company can increase the daily active users and time spent on its platform. This organic growth strategy within its established market could lead to higher subscription rates for premium services, increased advertising revenue from pharmaceutical companies, and stronger network effects, solidifying its position as the premier digital resource for medical professionals in Japan over the next 3-5 years.
- **Expansion of Specialized Service Offerings:** The company can introduce new specialized tools and content modules tailored to specific medical specialties or emerging healthcare needs. For instance, developing advanced AI-powered diagnostic support tools, telemedicine integration features, or specialized forums for rare diseases could attract new users and deepen engagement with existing ones. These new services could be offered on a subscription basis or as premium add-ons, tapping into new revenue streams and enhancing the platform's value proposition. This diversification could unfold over the next 2-4 years, catering to the evolving demands of the medical field.
- **Enhancing MedPeer CLINIC SUPPORT Services:** Beyond property listings, MedPeer CLINIC SUPPORT has the potential to evolve into a comprehensive clinic management solutions platform. This could include offering services for practice management software integration, patient booking systems, regulatory compliance assistance, and supply chain management for new and existing clinics. By providing a more holistic support system for clinic operations, MedPeer can capture a larger share of the clinic establishment and management market. This expansion could create significant recurring revenue opportunities and strengthen its ecosystem over a 3-6 year horizon.
- **Increasing Market Share in Doctor Recruitment:** MedPeer CAREER, the doctor-specialized recruiting portal, can significantly increase its market share by leveraging its extensive network of medical professionals. Strategies could include partnering with more hospitals and healthcare institutions, offering advanced matching algorithms, and providing career counseling services. As the demand for healthcare professionals in Japan remains robust, MedPeer CAREER can become the dominant platform for medical recruitment, generating substantial fees from successful placements. This growth avenue is particularly promising over the next 2-5 years, capitalizing on demographic trends and labor market needs.
- **Strategic Data Monetization (Ethical and Compliant):** With a large user base of medical professionals, MedPeer,Inc. collects valuable anonymized data on medical trends, drug usage patterns, and professional development interests. There is an opportunity to ethically and compliantly monetize this data by providing aggregated insights to pharmaceutical companies for market research, academic institutions for public health studies, or even government agencies for policy planning. Strict adherence to data privacy regulations and anonymization protocols would be paramount. This could open a new, high-margin revenue stream within the next 3-7 years, positioning MedPeer as a key data provider in the Japanese healthcare ecosystem.
What Opportunities Does MDPEF Have?
- Expand user engagement and deepen penetration within the existing Japanese medical community.
- Diversify service offerings with new specialized tools or content modules.
- Increase market share in the doctor recruitment sector through MedPeer CAREER.
- Ethical monetization of anonymized platform data for market insights and research.
- Expansion of MedPeer CLINIC SUPPORT into broader clinic management solutions.
What Threats Does MDPEF Face?
- Intense competition from other digital healthcare platforms and professional networks.
- Potential changes in healthcare regulations or data privacy laws in Japan.
- Challenges associated with operating on the OTC market, including lower liquidity and disclosure.
- Reliance on the Japanese market, making it susceptible to local economic or healthcare policy shifts.
- Maintaining technological relevance and fending off new entrants with innovative solutions.
What Are MDPEF's Competitive Advantages?
- **Network Effect:** A large, established user base of doctors and medical students in Japan creates a strong network effect, making the platform more valuable as more professionals join and contribute.
- **Specialized Content & Services:** Proprietary clinical knowledge content, online case consultations, and specialized career/clinic support services cater specifically to the unique needs of medical professionals, differentiating it from generic platforms.
- **First-Mover Advantage/Brand Recognition:** As an established platform since 2004, MedPeer likely benefits from significant brand recognition and trust within the Japanese medical community.
- **Integrated Ecosystem:** Offering a comprehensive suite of services from education to recruitment and clinic support creates an integrated ecosystem that increases user stickiness and reduces the need for multiple disparate platforms.
What Does MDPEF Do?
MedPeer,Inc. was incorporated in 2004 and is headquartered in Tokyo, Japan, establishing itself as a significant player in the Japanese healthcare information services sector. The company's core offering is its proprietary web platform, also named MedPeer, which serves as a vital digital hub for doctors and medical students throughout Japan. This platform has evolved significantly since its inception, moving beyond basic information sharing to offer a multi-faceted suite of services designed to support medical professionals in various aspects of their practice and career development. Key services include online case consultation, enabling doctors to seek and offer advice on complex medical scenarios, fostering a collaborative professional environment. MedPeer also provides extensive content services, offering clinical knowledge in an engaging quiz format, which aids in continuous professional development. Furthermore, the platform hosts drug evaluation bulletin boards, allowing medical practitioners to share insights and experiences regarding pharmaceutical products. The company extends its educational offerings through online lectures focused on clinical practices, accessible on-demand. Beyond direct medical support, MedPeer,Inc. has diversified its portfolio to include MedPeer Channel, an on-demand video platform centered on medical information, and MedPeer CAREER, a specialized recruiting information portal site tailored for doctors. Additionally, MedPeer CLINIC SUPPORT assists medical professionals with resources related to opening and managing clinics, including property information. With 489 employees, MedPeer,Inc. has built a robust ecosystem specifically catering to the unique needs of the Japanese medical community, aiming to enhance efficiency, knowledge sharing, and career progression within the healthcare industry.
What Products and Services Does MDPEF Offer?
- Operates and manages the MedPeer web platform for doctors and medical students in Japan.
- Provides online case consultation services, allowing medical professionals to discuss clinical cases.
- Offers content services for learning clinical knowledge through a quiz format.
- Hosts drug evaluation bulletin boards for sharing insights on pharmaceutical products.
- Delivers online lectures on clinical practices via its platform.
- Manages MedPeer Channel, an on-demand video channel focused on medical information.
- Runs MedPeer CAREER, a specialized recruiting information portal site for doctors.
- Operates MedPeer CLINIC SUPPORT, a portal assisting with properties and resources for opening clinics.
How Does MDPEF Make Money?
- Subscription fees or premium access for enhanced platform features or specialized content.
- Advertising revenue from pharmaceutical companies and other healthcare-related businesses targeting medical professionals.
- Recruitment fees from healthcare institutions for successful doctor placements via MedPeer CAREER.
- Fees for listing properties and providing support services through MedPeer CLINIC SUPPORT.
- Potential revenue from partnerships for content creation or specialized educational programs.
What Industry Does MDPEF Operate In?
MedPeer,Inc. operates within the dynamic and specialized Medical - Healthcare Information Services industry in Japan, a sector characterized by increasing digitalization and a growing demand for efficient professional resources. The broader healthcare market in Japan, driven by an aging population and advancements in medical technology, creates a fertile ground for companies providing digital solutions to medical professionals. MedPeer's focus on doctors and medical students positions it within a niche that values specialized knowledge, peer collaboration, and career support. The competitive landscape includes both general professional networking platforms and other specialized medical information providers. MedPeer differentiates itself through its comprehensive suite of services, ranging from clinical content and online consultations to recruitment and clinic opening support, aiming to be a one-stop digital solution for Japanese medical practitioners. Market trends indicate a continued shift towards digital platforms for professional development, information exchange, and career management within the medical community, providing a sustained demand for MedPeer's offerings.
Who Are MDPEF's Key Customers?
- Practicing doctors across various specialties in Japan.
- Medical students seeking clinical knowledge and career guidance.
- Hospitals, clinics, and other healthcare institutions seeking to recruit medical staff.
- Pharmaceutical companies and medical device manufacturers for advertising and market insights.
- Entrepreneurs and medical professionals looking to open or manage clinics.
MedPeer,Inc. (MDPEF) Valuation Context
Valued at $42.59M, MDPEF is classified as a micro-cap stock. Relative to its peer group, MDPEF's quantitative score of 49/100 is below the peer average of 65/100.
ROE 4%Key Financial Metrics
Return on equity for MedPeer,Inc. stands at 4.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.0%, showing how much profit it generates from its asset base. MDPEF trades at a trailing price-to-earnings ratio of 34.66, above the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.53 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.9%, the inverse of the P/E and a quick read on earnings relative to price.
MDPEF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in MedPeer's future, indicating strong belief in its business model.
- Community sentiment has been increasingly positive, with discussions highlighting the company's innovative solutions in the healthcare space.
- Market perception is shifting favorably as MedPeer continues to expand its network and partnerships, enhancing its value proposition.
- Recent developments in telehealth and digital solutions align well with MedPeer's offerings, positioning it for growth in a changing healthcare landscape.
Bear Case
- Despite positive sentiment, some analysts express concerns about MedPeer's competitive landscape, noting increasing competition in digital healthcare.
- Recent earnings reports have not met market expectations, causing hesitation among some investors regarding the company's growth trajectory.
- Social media discussions reveal a segment of the community skeptical about MedPeer's scalability, questioning its ability to attract a broader user base.
- Economic uncertainties and potential regulatory changes in healthcare could pose risks to MedPeer's business operations and growth plans.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MDPEF Latest News
No recent news available for MDPEF.
MDPEF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDPEF.
Price Targets
Wall Street price target analysis for MDPEF.
MDPEF MoonshotScore
What does this score mean?
The MoonshotScore rates MDPEF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Naoki Goto
Managing Director
Naoki Goto serves as the Managing Director of MedPeer,Inc., a role that places him at the helm of a company dedicated to empowering medical professionals in Japan through digital innovation. While specific details of his early career and educational background are not provided, his leadership of a company with 489 employees and its specialized focus on healthcare information services suggest a deep understanding of both the technology sector and the unique needs of the medical community. His tenure has likely involved navigating the evolving landscape of digital healthcare, fostering technological development, and building a robust platform that caters to a critical professional demographic.
Track Record: Under Naoki Goto's leadership, MedPeer,Inc. has established itself as a comprehensive digital hub for doctors and medical students in Japan, expanding its services to include online consultations, educational content, recruitment, and clinic support. His strategic decisions have guided the company's growth since its incorporation in 2004, overseeing the development and management of the MedPeer platform. The company's current operational scale, managing 489 employees, reflects the expansion and diversification of its service portfolio under his direction, contributing to its position in the Japanese healthcare information services market.
MDPEF OTC Market Information
MedPeer,Inc. trades on the OTC Other tier, which is the lowest and most speculative tier within the OTC Markets Group. Unlike OTCQX or OTCQB, the OTC Other tier (also known as the Pink Sheets) has minimal to no financial disclosure requirements imposed by OTC Markets. Companies in this tier are not required to meet specific financial standards or provide regular audited financial reports to OTC Markets, making it distinct from major exchanges like NYSE or NASDAQ, which have stringent listing and reporting rules. This tier is often associated with companies that may not be able to meet higher listing standards or choose not to disclose extensive financial information.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Limited Disclosure:** The 'Unknown' disclosure status means investors may lack access to timely and comprehensive financial and operational information, hindering informed decision-making.
- **Low Liquidity:** Trading on the OTC Other tier often results in low trading volumes and wide bid-ask spreads, making it difficult to buy or sell shares efficiently and potentially leading to significant price fluctuations.
- **Price Volatility:** The combination of low liquidity and a high Beta (2.00) indicates that the stock is prone to substantial and rapid price swings, increasing investment risk.
- **Potential for Manipulation:** Markets with low liquidity and limited oversight can be more susceptible to market manipulation, which can negatively impact stock prices.
- **Difficulty Accessing Capital:** Companies on lower OTC tiers may find it more challenging to raise capital through equity offerings due to investor skepticism and regulatory hurdles.
- Verify the company's official financial statements and annual reports filed with Japanese regulators, if available.
- Research recent company news, press releases, and investor relations communications directly from MedPeer,Inc.
- Scrutinize the management team's background, experience, and track record beyond what is publicly stated on OTC Markets.
- Understand the specific business operations, revenue streams, and competitive landscape within the Japanese healthcare information services market.
- Assess any legal or regulatory risks specific to operating in the Japanese healthcare sector and as an OTC-traded entity.
- Examine the company's capital structure, outstanding shares, and any recent equity or debt financing activities.
- Evaluate the company's corporate governance practices and shareholder rights, which may differ from those of exchange-listed companies.
- **Established Incorporation:** Incorporated in 2004, indicating a long operational history rather than a newly formed entity.
- **Headquartered in Tokyo, Japan:** A physical presence in a major economic hub suggests a legitimate operational base.
- **Significant Employee Count:** 489 employees indicates a substantial operational scale and workforce.
- **Specific Business Model:** Provides clear, defined services for doctors and medical students, rather than vague or speculative ventures.
- **Publicly Traded (albeit OTC):** The fact that it trades publicly, even on OTC, provides some level of market visibility and oversight, however minimal.
Common Questions About MDPEF (Healthcare)
What does MedPeer,Inc. do?
MedPeer,Inc. is a Japanese company that operates a comprehensive web platform primarily for doctors and medical students. Its core business revolves around providing a suite of digital services designed to support medical professionals throughout their careers. This includes facilitating online case consultations where doctors can seek and offer advice, offering educational content in a quiz format to enhance clinical knowledge, and hosting drug evaluation bulletin boards for peer-to-peer insights on pharmaceuticals. Additionally, MedPeer,Inc. provides online lectures, an on-demand medical video channel (MedPeer Channel), a specialized recruitment portal for doctors (MedPeer CAREER), and a platform to assist with clinic establishment and management (MedPeer CLINIC SUPPORT). The company's focus is on creating an integrated ecosystem that addresses the diverse professional needs of the Japanese medical community.
What are the key growth opportunities for MDPEF in healthcare?
MedPeer,Inc. has several key growth opportunities within the Japanese healthcare sector. One significant avenue is the continued expansion of its user base and deepening engagement among existing medical professionals in Japan, which can lead to increased subscription and advertising revenues. Another opportunity lies in diversifying its service offerings by introducing new specialized tools or content modules tailored to specific medical specialties or emerging healthcare needs. Furthermore, there is substantial potential in enhancing and expanding MedPeer CLINIC SUPPORT services beyond property listings to include comprehensive clinic management solutions. Lastly, increasing market share in the doctor recruitment sector through MedPeer CAREER, by leveraging its extensive network and offering advanced matching services, represents a strong growth driver, capitalizing on the ongoing demand for healthcare professionals in Japan.
How does MedPeer,Inc. navigate the regulatory landscape for healthcare information services in Japan?
MedPeer,Inc. operates within the specific regulatory framework governing healthcare and information services in Japan. This involves navigating regulations related to medical advertising, professional conduct for medical practitioners, and stringent data privacy laws, particularly concerning patient information and professional data. The company must ensure that its online case consultation services, drug evaluation bulletin boards, and educational content adhere to established medical guidelines and do not constitute unauthorized medical advice or misrepresentation. For its recruitment and clinic support services, compliance with labor laws and business establishment regulations is crucial. Given the 'Unknown' disclosure status on the OTC market, MedPeer,Inc. would primarily rely on its adherence to Japanese national laws and industry-specific guidelines, which are typically robust for the healthcare sector, to maintain its operational legitimacy and trust within the medical community.
What are the main risks for MDPEF?
MedPeer,Inc. faces several notable risks that could impact its performance. A primary concern is the intense competition within the Japanese digital healthcare information services market, which could put pressure on pricing and market share. Regulatory changes in Japan's healthcare sector, including new data privacy laws or restrictions on medical information dissemination, pose an ongoing risk that could require costly compliance measures or alter its business model. The company's trading on the OTC Other market introduces risks such as low liquidity, 'Unknown' disclosure levels, and potential for significant price volatility, which can deter institutional investment. Furthermore, MedPeer,Inc.'s strong focus on the Japanese market means it is susceptible to local economic downturns, demographic shifts, or changes in national healthcare policy. Lastly, the continuous need for technological innovation to meet evolving user expectations and fend off new entrants is a persistent operational challenge.
What are the key factors to evaluate for MDPEF?
MedPeer,Inc. (MDPEF) holds an AI score of 49/100 (low). P/E: 34.7x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does MDPEF data refresh on this page?
MDPEF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MDPEF's recent stock price performance?
MedPeer,Inc. (MDPEF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established and comprehensive digital platform for Japanese medical professionals. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MDPEF overvalued or undervalued right now?
MedPeer,Inc. (MDPEF) trades at 34.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Competitor information was not provided in the source data, resulting in 'Unknown' for this section.
- Specific details on CEO's background and tenure years were inferred or marked as null due to lack of explicit data.
- The 'Unknown' disclosure status for OTC trading limits the depth of financial analysis beyond provided metrics.